Financial Year |
March 31 2023 |
Monetary Funds |
1,460,946,936.72 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
24,636,740.10 |
Accounts Receivable |
1,088,584,614.28 |
Advances to Suppliers |
12,723,551.54 |
Other Receivables |
22,666,482.71 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
626,459,368.85 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
29,830,971.01 |
Total Current Assets |
3,265,848,665.21 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
30,146,872.06 |
Long-term Equity Investment |
131,405,403.71 |
Investment Properties |
233,834,256.61 |
Fixed Assetes |
162,696,743.90 |
Under-construction Projects |
106,204,423.24 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
139,213,267.46 |
R&D expenses |
1,357,766.48 |
Goodwill |
12,690,843.48 |
Long-Term Deferred and Prepaid Expenses |
9,497,324.21 |
Deferred Income Tax Assets |
3,575,236.35 |
Other Non-Current Assets |
-- |
Sub-Total of Non-Current Assets |
831,122,137.50 |
Total Assets |
4,096,970,802.71 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
12,138,500.28 |
Accounts Payable |
303,609,400.69 |
Accounts Received In Advance |
9,281,299.68 |
Employee Compensation Payable |
29,711,152.79 |
Taxes Payable |
9,882,371.76 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
220,757,066.14 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
-- |
Other Current Liabilities |
54,689,152.33 |
Sub-Total of Current Liabilities |
679,145,518.47 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
100,000.00 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
3,016,390.95 |
Total Liabilities |
682,161,909.42 |
Paid-In Capital(Or Share Stock) |
1,256,000,064.00 |
Capital Surplus |
919,833,228.89 |
Surplus Reserve |
158,123,544.48 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
1,037,305,197.33 |
Minority Stockholder's Interest |
42,608,915.15 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,372,199,978.14 |
Owner's Equity(Stockholder's Equity) |
3,414,808,893.29 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
4,096,970,802.71 |